Deadly measles outbreaks on the rise
Approximately 21 million children worldwide are not having measles vaccinations every year, substantially increasing their risk of raising the risk of the disease later in life. These new
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XApproximately 21 million children worldwide are not having measles vaccinations every year, substantially increasing their risk of raising the risk of the disease later in life. These new
A network that connects every NHS acute hospital in England is giving thousands of patients unprecedented and easy online access to everything from their x-rays through to ultrasound,
Multiple new genes involved in hearing loss have been revealed in a large study of mouse mutants by researchers from the Wellcome Sanger Institute and King’s College London.
Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases
A research roadmap has just been published in the journal Radiology, which highlights knowledge gaps in the literature. This was produced following a workshop held in August of
Glioblastoma is one of the most devastating types of cancer, with few existing treatment options. It is a leading cause of cancer-related death in both children and young
Over half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, according to research published in the journal Heart.
Muskoka Canterpene Bio Derivatives (MCBD) was established in 2017 in beautiful Gravenhurst, Ontario, Canada. With one thing in mind, better health MCBD manufactures tinctures, creams and capsules using Canterpene,
China’s National Health Commission (NHC) has stated that it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines. Zeng
Gnubiotics Sciences SA is a Swiss biotech company pioneering the development of products from complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal and human